Literature DB >> 19535777

Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.

Sergio Giralt, David H Vesole, George Somlo, Amrita Krishnan, Edward Stadtmauer, Philip Mccarthy, Marcelo C Pasquini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19535777      PMCID: PMC4415058          DOI: 10.1093/jnci/djp126

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

1.  Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial.

Authors:  Pieter Sonneveld; Bronno van der Holt; Christine M Segeren; Edo Vellenga; Alexandra J Croockewit; Gregor E G Verhoe; Jan J Cornelissen; Martijn R Schaafsma; Marinus H J van Oers; Pierre W Wijermans; Petra H M Westveer; Henk M Lokhorst
Journal:  Haematologica       Date:  2007-07       Impact factor: 9.941

2.  Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial.

Authors:  Philippe Moreau; Thierry Facon; Michel Attal; Cyrille Hulin; Mauricette Michallet; Frédéric Maloisel; Jean-Jacques Sotto; François Guilhot; Gérald Marit; Chantal Doyen; Jérôme Jaubert; Jean-Gabriel Fuzibet; Sylvie François; Lotfi Benboubker; Matthieu Monconduit; Laurent Voillat; Margaret Macro; Christian Berthou; Véronique Dorvaux; Bernard Pignon; Bernard Rio; Thomas Matthes; Philippe Casassus; Denis Caillot; Norbert Najman; Bernard Grosbois; Régis Bataille; Jean-Luc Harousseau
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

3.  Maintenance therapy with thalidomide improves survival in patients with multiple myeloma.

Authors:  Michel Attal; Jean-Luc Harousseau; Serge Leyvraz; Chantal Doyen; Cyrille Hulin; Lofti Benboubker; Ibrahim Yakoub Agha; Jean-Henri Bourhis; Laurent Garderet; Brigitte Pegourie; Charles Dumontet; Marc Renaud; Laurent Voillat; Christian Berthou; Gerald Marit; Mathieu Monconduit; Denis Caillot; Bernard Grobois; Herve Avet-Loiseau; Philippe Moreau; Thierry Facon
Journal:  Blood       Date:  2006-07-27       Impact factor: 22.113

4.  Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trial.

Authors:  Abderrahman Abdelkefi; Saloua Ladeb; Lamia Torjman; Tarek Ben Othman; Amel Lakhal; Neila Ben Romdhane; Halima El Omri; Moez Elloumi; Hatem Belaaj; Ramzi Jeddi; Lamia Aissaouï; Habib Ksouri; Assia Ben Hassen; Fahmi Msadek; Ali Saad; Mohamed Hsaïri; Kamel Boukef; Ahlem Amouri; Hechmi Louzir; Koussay Dellagi; Abdeladhim Ben Abdeladhim
Journal:  Blood       Date:  2007-09-17       Impact factor: 22.113

Review 5.  Tandem versus single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.

Authors:  Ambuj Kumar; Mohamed A Kharfan-Dabaja; Axel Glasmacher; Benjamin Djulbegovic
Journal:  J Natl Cancer Inst       Date:  2009-01-13       Impact factor: 13.506

6.  Clinically relevant end points and new drug approvals for myeloma.

Authors:  K C Anderson; R A Kyle; S V Rajkumar; A K Stewart; D Weber; P Richardson
Journal:  Leukemia       Date:  2007-11-01       Impact factor: 11.528

  6 in total
  2 in total

Review 1.  The Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell Transplantation.

Authors: 
Journal:  Biol Blood Marrow Transplant       Date:  2016-07-11       Impact factor: 5.742

2.  International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.

Authors:  Michele Cavo; S Vincent Rajkumar; Antonio Palumbo; Philippe Moreau; Robert Orlowski; Joan Bladé; Orhan Sezer; Heinz Ludwig; Meletios A Dimopoulos; Michel Attal; Pieter Sonneveld; Mario Boccadoro; Kenneth C Anderson; Paul G Richardson; William Bensinger; Hans E Johnsen; Nicolaus Kroeger; Gösta Gahrton; P Leif Bergsagel; David H Vesole; Hermann Einsele; Sundar Jagannath; Ruben Niesvizky; Brian G M Durie; Jesus San Miguel; Sagar Lonial
Journal:  Blood       Date:  2011-03-29       Impact factor: 22.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.